Treatment of Substance-Related and Addictive Disorders

Assignment: Treatment of Substance-Related and Addictive Disorders

Hallucinogen -Related Disorders

Explain the diagnostic criteria for your assigned substance-related and addictive disorder ( Hallucinogen related disorder).
Explain the evidenced-based psychotherapy and psychopharmacologic treatment for your assigned substance-related and addictive disorder.
Describe clinical features that you would expect to observe in a client that may have the substance-related and addictive disorder you were assigned. Align the clinical features with the DSM-5 criteria.
Support your rationale with references to the Learning Resources or other academic resources.

Required Readings( Need 3 + reference).

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.

· Chapter 20, “Substance Use and Addictive Disorders” (pp. 616–693)

Stahl, S. M. (2017). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (6th ed.). New York, NY: Cambridge University Press.
To access information on specific medications, click on The Prescriber’s Guide, 6th Ed. tab on the Stahl Online website and select the appropriate medication.

Alcohol abstinence

Alcohol dependence

Alcohol withdrawal

Nicotine addiction

Opioid dependence

Reversal of benzodiazepine effects

acamprosate
disulfiram

nalmefene
naltrexone

chlordiazepoxide
clonidine
clorazepate
diazepam
lorazepam
oxazepam

bupropin
varenicline

buprenorphine
naltrexone

flumazenil

Note: For more information about buprenorphine, see https: //www.samhsa.gov/medication-assisted-treatment/qualify-nps-pas-waivers

Required Media

Ashwood, D. (Producer). (n.d.-a). Mindfulness-based relapse prevention for addictions: Volume I [Video file]. Mill Valley, CA: Psychotherapy.net.

Note: The approximate length of this media piece is 69 minutes.

Ashwood, D. (Producer). (n.d.-b). Mindfulness-based relapse prevention for addictions: Volume II [Video file]. Mill Valley, CA: Psycotherapy.net.

Note: The approximate length of this media piece is 126 minutes.

Optional Resources

Bechtold, J., Simpson, T., White, H. R., & Pardini, D. (2015). Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychology of Addictive Behaviors, 29(3), 552–563. doi:10.1037/adb0000103

Note: You will access this article from the Walden Library databases.

Borchardt, D. (2017). National Academy of Sciences pushes for rescheduling of marijuana. Forbes. Retrieved from https://www.forbes.com/sites/debraborchardt/2017/01/18/national-academy-of-sciences-suggests-removing-barriers-to-cannabis-research-basically-deschedule/#22269c753f76

Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications.

· Chapter 46, “Alcohol-Related Disorders”

· Chapter 47, “Sedative-, Hypnotic-, or Anxiolytic-Related Disorders”

· Chapter 48, “Opioid-Related Disorders: Opioid Detoxification”

· Chapter 49, “Opioid-Related Disorders: Antagonist Treatment”

· Chapter 50, “Opioid-Related Disorders: Agonist Maintenance Treatment”

· Chapter 51, “Hallucinogen-Related Disorders

· Chapter 52, “Cannabis-Related Disorders”

· Chapter 53, “Club Drug Addiction”

· Chapter 54, “Stimulant-Related Disorders”